Latest Articles

PCSK9 inhibitors and ACS

Lipid-lowering therapy and care gap in patients with Familial Hypercholesterolemia

Recommendations on treatment simplification of complex insulin regimens to improve clinical outcomes in patients with T2DM

Closed-loop insulin delivery during exercise in people with T1DM

iGlarLixi Enables Safe Ramadan Fasting for Most T2D Patients

New 2022 ADA/EASD Guidelines: GLPP-1 RA/Insulin Combination Is Recommended

ADA/EASD recommend considering combination injectables therapy of basal insulin/GLP-1 RA (Such as Soliqua^®) as valuable treatment option to provide adequate efficacy for achieving and maintaining glycemic goals.

Diabetes management during Ramadan

Management of athletes and active people with diabetes - The American Medical Society for Sports Medicine (AMSSM) scientific statement

Post-exercise hypoglycemia in relation to medication regimen among adults with type 2 diabetes